FDA Approves First Renal Denervation System for Hypertension Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Booms Health news and commentary from around the Web gathered by ѿapp staff Nov 08, 2023
Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgery Pause on ACE inhibitors, ARBs yields more acute hypertension with no prevention of hypotension Nov 06, 2023
Kidney Transplant Rates Stubbornly Resist Systems Intervention in Canada Multi-pronged approach to boost living and deceased donor transplant fails in randomized trial Nov 06, 2023
Sparsentan Bests Irbesartan for Preserving Kidney Function in IgA Nephropathy Proteinuria reduction and slower eGFR decline in 2-year PROTECT trial Nov 05, 2023
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
Pharmacist Prescribing for BP Control Makes Economic Sense Clinical benefits of pharmacist-prescribed antihypertensives known for years Nov 03, 2023
Sparsentan Failed to Preserve Kidney Function Over Time in FSGS However, more patients on the drug achieved partial remission of proteinuria vs irbesartan Nov 03, 2023
Mid-Stage Win for Novel IgA Nephropathy Drug APRIL-neutralizing antibody sibeprenlimab reduced proteinuria and stabilized eGFR Nov 02, 2023
Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens Multidrug resistant organisms replaced by competing antibiotic-susceptible relatives Nov 01, 2023
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by ѿapp staff Oct 30, 2023
Tricuspid Valve Replacement Safe, Effective in Pivotal Trial Outcome data still awaited after positive interim results Oct 27, 2023
Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
Cruise Line Found Negligent About COVID; Dialysis Machine Recall; MRI Injures Nurse Health news and commentary from around the Web gathered by ѿapp staff Oct 25, 2023
Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials Oct 24, 2023
CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by ѿapp staff Oct 20, 2023
Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
How to Deprescribe Dialysis After Patients Leave the Hospital Acute kidney injury patients should not be left on dialysis longer than necessary Oct 19, 2023
FDA Approves First Phosphate Absorption Inhibitor for CKD Tenapanor indicated for adults on dialysis who fail on phosphate binders Oct 18, 2023
Antibiotic Combo for Acute Infection Cleared of Kidney Risk Use of cefepime meanwhile resulted in more neurological dysfunction Oct 16, 2023
'Surprising' Contribution of Pulmonary Hypertension to ARDS Outcomes Coexisting conditions spell markedly poor clinical course Oct 12, 2023
Modest Risks Come With Moving Fast on HF Drugs After Acute Event STRONG-HF analysis details the impact Oct 10, 2023
Risk of Contrast Media Causing Acute Kidney Injury Is Overblown, Study Finds Despite restrictions on its use, an association with kidney injury hasn't been shown Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Adherence Matters for CVD Secondary Prevention in CPAP Users Questionable benefit may hinge on number of hours used Oct 05, 2023
Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
FDA OKs Another Injectable for Rare Kidney Disorder Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023